1. Home
  2. BORR vs SVRA Comparison

BORR vs SVRA Comparison

Compare BORR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$4.46

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$5.60

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BORR
SVRA
Founded
2016
2007
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
BORR
SVRA
Price
$4.46
$5.60
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$6.25
$7.33
AVG Volume (30 Days)
5.7M
1.5M
Earning Date
05-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.80
N/A
Revenue Next Year
$21.67
$430.87
P/E Ratio
$20.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$3.19
52 Week High
$6.66
$7.01

Technical Indicators

Market Signals
Indicator
BORR
SVRA
Relative Strength Index (RSI) 56.99 52.55
Support Level $3.74 $5.20
Resistance Level $4.51 $6.09
Average True Range (ATR) 0.21 0.26
MACD 0.05 0.02
Stochastic Oscillator 80.52 58.82

Price Performance

Historical Comparison
BORR
SVRA

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: